KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) EPS (Weighted Average and Diluted) (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of EPS (Weighted Average and Diluted) data on record, last reported at $3.09 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 17.94% year-over-year to $3.09; the TTM value through Dec 2025 reached $13.08, up 22.59%, while the annual FY2025 figure was $13.08, 22.59% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $3.09 in Q4 2025 per IDXX's latest filing, down from $3.4 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $3.63 in Q2 2025 and bottomed at $1.56 in Q2 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $2.52, with a median of $2.48 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 82.17% in 2021, then crashed 33.33% in 2022.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $1.89 in 2021, then grew by 8.99% to $2.06 in 2022, then increased by 12.14% to $2.31 in 2023, then rose by 13.42% to $2.62 in 2024, then grew by 17.94% to $3.09 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $3.09 in Q4 2025, $3.4 in Q3 2025, and $3.63 in Q2 2025.